Literature DB >> 29750819

Correction: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?

Bárbara Alemar, Cleandra Gregório, Josef Herzog, Camila Matzenbacher Bittar, Cristina Brinckmann Oliveira Netto, Osvaldo Artigalas, Ida Vanessa D Schwartz, Jordy Coffa, Suzi Alves Camey, Jeffrey Weitzel, Patricia Ashton-Prolla.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0187630.].

Entities:  

Year:  2018        PMID: 29750819      PMCID: PMC5947889          DOI: 10.1371/journal.pone.0197529

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


There is an error in the XML that is causing the fourteenth author’s name, Ida Vanessa D. Schwartz, to be indexed incorrectly. The name should be indexed as Schwartz, IVD. There is an error in the seventh sentence of the fifth paragraph of the Discussion section. The correct sentence is: Therefore, it is surprising that in our population 2.5% of all carriers were double heterozygotes besides one patient carrying two BRCA2 pathogenic variants. In the Author Contribution section, Bárbara Alemar (BA) should be listed as one of the persons who took part in the conceptualization of the paper.
  1 in total

1.  BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?

Authors:  Bárbara Alemar; Cleandra Gregório; Josef Herzog; Camila Matzenbacher Bittar; Cristina Brinckmann Oliveira Netto; Osvaldo Artigalas; Ida Vanessa D Schwartz; Jordy Coffa; Suzi Alves Camey; Jeffrey Weitzel; Patricia Ashton-Prolla
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

  1 in total
  1 in total

1.  Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).

Authors:  Fatima Zahra El Ansari; Farah Jouali; Nabila Marchoudi; Mohcine Mechita Bennani; Naima Nourouti Ghailani; Amina Barakat; Jamal Fekkak
Journal:  BMC Cancer       Date:  2020-08-10       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.